| Name | Walgreens #01879 |
|---|---|
| Organization Name | Walgreen Eastern Co Inc |
| Location | 2151 Lemoine Ave, Fort Lee, New Jersey 07024 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (201) 947-6772 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
The American Diabetes Association has awarded Joslin Diabetes Center assistant investigator Aleksandar Kostic, Ph.D., a $1.625-million grant under its Pathway to Stop Diabetes program, which seeks to bring new investigators and new perspectives to diabetes research.
Endologix, Inc., developer of minimally invasive treatments for aortic disorders, announced today that it has completed the acquisition of Nellix, Inc. Nellix has developed a revolutionary new device for the treatment of Abdominal Aortic Aneurysms (AAAs) that is expected to address the limitations of existing endovascular aneurysm repair (EVAR) devices and expand the global AAA market. Endologix announced its agreement to acquire Nellix on October 27, 2010.
Scientists in the University of Connecticut's Technology Incubation Program have identified a novel approach to treating multiple sclerosis (MS) using human embryonic stem cells, offering a promising new therapy for more than 2.3 million people suffering from the debilitating disease.
M3 USA, together with Bristol-Myers Squibb, is launching a pilot program to oncologists using M3's next-generation eLearning and eMarketing solution. The solution – M3 Messages™ – takes a new approach to developing valuable, long-term, online connections that help doctors stay current on advances in oncology.
› Verified 3 days ago
| NPI Number | 1356356331 |
| Organization Name | WALGREEN EASTERN CO, INC |
| Doing Business As | WALGREENS #01879 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 2151 Lemoine Ave, Fort Lee, NJ 07024 |
| Phone Number | 201-947-6772 |
News Archive
The American Diabetes Association has awarded Joslin Diabetes Center assistant investigator Aleksandar Kostic, Ph.D., a $1.625-million grant under its Pathway to Stop Diabetes program, which seeks to bring new investigators and new perspectives to diabetes research.
Endologix, Inc., developer of minimally invasive treatments for aortic disorders, announced today that it has completed the acquisition of Nellix, Inc. Nellix has developed a revolutionary new device for the treatment of Abdominal Aortic Aneurysms (AAAs) that is expected to address the limitations of existing endovascular aneurysm repair (EVAR) devices and expand the global AAA market. Endologix announced its agreement to acquire Nellix on October 27, 2010.
Scientists in the University of Connecticut's Technology Incubation Program have identified a novel approach to treating multiple sclerosis (MS) using human embryonic stem cells, offering a promising new therapy for more than 2.3 million people suffering from the debilitating disease.
M3 USA, together with Bristol-Myers Squibb, is launching a pilot program to oncologists using M3's next-generation eLearning and eMarketing solution. The solution – M3 Messages™ – takes a new approach to developing valuable, long-term, online connections that help doctors stay current on advances in oncology.
› Verified 3 days ago
News Archive
The American Diabetes Association has awarded Joslin Diabetes Center assistant investigator Aleksandar Kostic, Ph.D., a $1.625-million grant under its Pathway to Stop Diabetes program, which seeks to bring new investigators and new perspectives to diabetes research.
Endologix, Inc., developer of minimally invasive treatments for aortic disorders, announced today that it has completed the acquisition of Nellix, Inc. Nellix has developed a revolutionary new device for the treatment of Abdominal Aortic Aneurysms (AAAs) that is expected to address the limitations of existing endovascular aneurysm repair (EVAR) devices and expand the global AAA market. Endologix announced its agreement to acquire Nellix on October 27, 2010.
Scientists in the University of Connecticut's Technology Incubation Program have identified a novel approach to treating multiple sclerosis (MS) using human embryonic stem cells, offering a promising new therapy for more than 2.3 million people suffering from the debilitating disease.
M3 USA, together with Bristol-Myers Squibb, is launching a pilot program to oncologists using M3's next-generation eLearning and eMarketing solution. The solution – M3 Messages™ – takes a new approach to developing valuable, long-term, online connections that help doctors stay current on advances in oncology.
› Verified 3 days ago
K&s Drug & Surgical Inc Type: Pharmacy Location: 266 Columbia Ave, Fort Lee, New Jersey 07024 Phone: (201) 886-9191 | |
Royal Pharmacy Type: Durable Medical Equipment & Medical Supplies Supplier Location: 1424 Bergen Blvd, Fort Lee, New Jersey 07024 Phone: (201) 482-0801 | |
Cvs Pharmacy #10655 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 165 Main St, Fort Lee, New Jersey 07024 Phone: (201) 944-5394 | |
Cvs Pharmacy #00481 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 1475 Bergen Blvd, Fort Lee, New Jersey 07024 Phone: (201) 947-4840 | |
Cvs Pharmacy #01269 Type: Community/Retail Pharmacy Location: 1681 Fletcher Ave, Fort Lee, New Jersey 07024 Phone: (201) 944-1214 |